1-7 of 7
Pierre Bories
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Late failure of aggressive B-cell lymphoma following CAR T-cell therapy: a LYSA study from the DESCAR-T registry

Open Access
Federico Erbella, Emmannuel Bachy, Guillaume Cartron, Elodie Gat, Guillaume Manson, Franck Morschhauser, Francois-Xavier Gros, Louise Roulin, Benoit Tessoulin, Pierre Bories, Olivier Tournilhac, Laure Ricard, Stephanie Guidez, Sylvain Choquet, René-Olivier Casasnovas, Gabriel Brisou, Arnaud Campidelli, Cristina Castilla-Llorente, Fabrice Jardin, Emmanuel Gyan, Blandine Guffroy, Julie Abraham, Justine Decroocq, Adrien Chauchet, Magalie Joris, Fabien Claves, Sylvain Carras, Gaelle Guillerm, Michael Loschi, Olivier Hermine, Aline Schmidt, Steven Le Gouill, Roch Houot, Roberta Di Blasi
Journal: Blood Advances
Blood Adv bloodadvances.2025016727.
https://doi.org/10.1182/bloodadvances.2025016727
Published: 2025
Includes: Supplemental data
Journal Articles

Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French study

Open Access
Sarah Cayla, Lionel Karlin, Jerome Lambert, Anne Lazareth, Alexis Talbot, Mohamad Mohty, Florent Malard, Marie-Odile Petillon, Salomon Manier, Ibrahim Yakoub-Agha, Denis Caillot, Ingrid Lafon, Xavier Leleu, Niels Moya, Bruno Royer, Jean Marc Schiano de Colella, Gabriel Brisou, Cyrille Touzeau, Aurore Perrot, Pierre Bories, Laure Vincent, Hanane Guedon, Olivier Decaux, Benoît Ferment, Roch Houot, Steven Le Gouill, Noemie Bigot, Thierry Facon, Jill Corre, Hervé Avet-Loiseau, Philippe Moreau, Bertrand Arnulf
Journal: Blood Advances
Blood Adv bloodadvances.2025017597.
https://doi.org/10.1182/bloodadvances.2025017597
Published: 2025
Includes: Supplemental data
Journal Articles

Gut microbiota restoration with oral pooled fecal microbiotherapy after intensive chemotherapy: the phase 1b CIMON trial

Open Access
Clinical Trials & Observations
Florent Malard, Sylvain Thepot, Thomas Cluzeau, Martin Carré, Delphine Lebon, Pierre Bories, Ollivier Legrand, Marianne Schwarz, Michael Loschi, Mathieu Meunier, Magalie Joris, Cyrielle Gasc, Juliette Jouve, Benoît Levast, Emilie Plantamura, Emmanuel Prestat, Antoine Sabourin, Béatrice Gaugler, Joel Dore, Christian Récher, Mohamad Mohty
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3739–3749.
https://doi.org/10.1182/bloodadvances.2024015571
Published: 2025
Includes: Supplemental data
Journal Articles

Outcome of high-grade B-cell lymphoma compared with other large B-cell lymphoma after CAR-T rescue: a DESCAR-T LYSA study

Open Access
Xavier Phina-Ziebin, Emmanuel Bachy, François-Xavier Gros, Roberta Di Blasi, Charles Herbaux, Jacques Olivier Bay, Sylvain Carras, Pierre Bories, Olivier Casasnovas, Fabrice Jardin, Franck Morschhauser, Blandine Guffroy, Mohamad Mohty, Elodie Gat, Julien Calvani, Marie-Cécile Parrens, Elsa Poullot, Alexandra Traverse-Glehen, Louise Roulin
Journal: Blood Advances
Blood Adv (2025) 9 (10): 2500–2510.
https://doi.org/10.1182/bloodadvances.2024014732
Published: 2025
Includes: Supplemental data
Journal Articles

Nonrelapse mortality after CAR T-cell therapy for large B-cell lymphoma: a LYSA study from the DESCAR-T registry

Free
Clinical Trials & Observations
Jean Lemoine, Emmanuel Bachy, Guillaume Cartron, David Beauvais, Thomas Gastinne, Roberta Di Blasi, Marie-Thérèse Rubio, Stéphanie Guidez, Mohamad Mohty, Rene-Olivier Casasnovas, Magalie Joris, Cristina Castilla-Llorente, Corinne Haioun, Olivier Hermine, Michael Loschi, Sylvain Carras, Pierre Bories, Tom Fradon, Charles Herbaux, Pierre Sesques, Steven Le Gouill, Franck Morschhauser, Catherine Thieblemont, Roch Houot
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6589–6598.
https://doi.org/10.1182/bloodadvances.2023010624
Published: 2023
Includes: Supplemental data
Journal Articles

The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11

Free
Clinical Trials & Observations
Marina Lafage-Pochitaloff, Bastien Gerby, Véronique Baccini, Laetitia Largeaud, Vincent Fregona, Naïs Prade, Pierre-Yves Juvin, Laura Jamrog, Pierre Bories, Sylvie Hébrard, Stéphanie Lagarde, Véronique Mansat-De Mas, Oliver M. Dovey, Kosuke Yusa, George S. Vassiliou, Joop H. Jansen, Tobias Tekath, David Rombaut, Geneviève Ameye, Carole Barin, Audrey Bidet, John Boudjarane, Marie-Agnès Collonge-Rame, Carine Gervais, Antoine Ittel, Christine Lefebvre, Isabelle Luquet, Lucienne Michaux, Nathalie Nadal, Hélène A. Poirel, Isabelle Radford-Weiss, Bénédicte Ribourtout, Steven Richebourg, Stéphanie Struski, Christine Terré, Isabelle Tigaud, Dominique Penther, Virginie Eclache, Michaela Fontenay, Cyril Broccardo, Eric Delabesse,
Journal: Blood Advances
Blood Adv (2022) 6 (2): 386–398.
https://doi.org/10.1182/bloodadvances.2021005311
Published: 2022
Includes: Supplemental data
Journal Articles

Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma

Free
Clinical Trials & Observations
Laetitia Vercellino, Roberta Di Blasi, Salim Kanoun, Benoit Tessoulin, Cedric Rossi, Maud D'Aveni-Piney, Lucie Obéric, Caroline Bodet-Milin, Pierre Bories, Pierre Olivier, Ingrid Lafon, Alina Berriolo-Riedinger, Eugenio Galli, Sophie Bernard, Marie-Thérèse Rubio, Celine Bossard, Veronique Meignin, Pascal Merlet, Pierre Feugier, Steven Le Gouill, Loic Ysebaert, Olivier Casasnovas, Michel Meignan, Sylvie Chevret, Catherine Thieblemont
Journal: Blood Advances
Blood Adv (2020) 4 (22): 5607–5615.
https://doi.org/10.1182/bloodadvances.2020003001
Published: 2020
Includes: Supplemental data